Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (111-120 of 748) with videos related to

Pageof 75
Sort By:
The New England Journal of Medicine|October 27, 2020
RAAS Inhibitors and Risk of Covid-19Krishna Sriram, Rohit Loomba, Paul A Insel
Gastroenterology|July 27, 2025
Emerging Role of Phosphatidylethanol Testing in Clinical Practice for the Identification of Steatotic Liver Disease Subtypes: Is This the New Standard?Rohit Loomba, Hannes Hagström, Luis Antonio Díaz
Alimentary Pharmacology & Therapeutics|November 9, 2022
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLDMaral Amangurbanova, Daniel Q Huang, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2019
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver DiseasePaul J Mills, Cyrielle Caussy, Rohit Loomba
Metabolism: Clinical and Experimental|May 11, 2020
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver diseaseMichelle T Long, Sanil Gandhi, Rohit Loomba
Journal of Hepatology|July 13, 2025
Comment on "Bringing genetic testing into the clinical management of people with MASLD: Are we there yet?"Luis Antonio Díaz, Rohit Loomba, Veeral Ajmera
Seminars in Liver Disease|March 26, 2024
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical PracticeClémence M Canivet, Jérôme Boursier, Rohit Loomba
Gastroenterology|November 25, 2021
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic SteatohepatitisRohit Loomba, Vlad Ratziu, Stephen A Harrison, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2018
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to FunctionSuzanne R Sharpton, Veeral Ajmera, Rohit Loomba
American Journal of Therapeutics|February 15, 2011
The need for novel anticoagulation therapy in acute coronary syndromeSuraj Chandrasekar, Rohit Loomba, Parinda Shah, et al.
Pageof 75

Showing results (111-120 of 748) with videos related to

Sort By:
Pageof 75
The New England Journal of Medicine|October 27, 2020
RAAS Inhibitors and Risk of Covid-19Krishna Sriram, Rohit Loomba, Paul A Insel
Gastroenterology|July 27, 2025
Emerging Role of Phosphatidylethanol Testing in Clinical Practice for the Identification of Steatotic Liver Disease Subtypes: Is This the New Standard?Rohit Loomba, Hannes Hagström, Luis Antonio Díaz
Alimentary Pharmacology & Therapeutics|November 9, 2022
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLDMaral Amangurbanova, Daniel Q Huang, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2019
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver DiseasePaul J Mills, Cyrielle Caussy, Rohit Loomba
Metabolism: Clinical and Experimental|May 11, 2020
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver diseaseMichelle T Long, Sanil Gandhi, Rohit Loomba
Journal of Hepatology|July 13, 2025
Comment on "Bringing genetic testing into the clinical management of people with MASLD: Are we there yet?"Luis Antonio Díaz, Rohit Loomba, Veeral Ajmera
Seminars in Liver Disease|March 26, 2024
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical PracticeClémence M Canivet, Jérôme Boursier, Rohit Loomba
Gastroenterology|November 25, 2021
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic SteatohepatitisRohit Loomba, Vlad Ratziu, Stephen A Harrison, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2018
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to FunctionSuzanne R Sharpton, Veeral Ajmera, Rohit Loomba
American Journal of Therapeutics|February 15, 2011
The need for novel anticoagulation therapy in acute coronary syndromeSuraj Chandrasekar, Rohit Loomba, Parinda Shah, et al.
Pageof 75